168 related articles for article (PubMed ID: 27457184)
1. Activated prothrombin complex concentrate in combination with tranexamic acid: a single centre experience for the treatment of mucosal bleeding and dental extraction in haemophilia patients with inhibitors.
Windyga J; Stefanska-Windyga E; Odnoczko E; Baran B; Czubak G
Haemophilia; 2016 Sep; 22(5):e465-8. PubMed ID: 27457184
[No Abstract] [Full Text] [Related]
2. Combined treatment with APCC (FEIBA®) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A--a two-centre experience.
Holmström M; Tran HT; Holme PA
Haemophilia; 2012 Jul; 18(4):544-9. PubMed ID: 22348384
[TBL] [Abstract][Full Text] [Related]
3. Successful use of tranexamic acid in the management of haemophilic pseudotumour.
Sagheer S; Atkins A; McRae S
Haemophilia; 2016 Jul; 22(4):e306-9. PubMed ID: 27291716
[No Abstract] [Full Text] [Related]
4. Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors.
Tran HT; Sørensen B; Rea CJ; Bjørnsen S; Ueland T; Pripp AH; Tjønnfjord GE; Holme PA
Haemophilia; 2014 May; 20(3):369-75. PubMed ID: 24251535
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of recombinant activated factor VII vs. plasma-derived activated prothrombin complex concentrate in the treatment of mild-to-moderate bleeding episodes in patients with severe haemophilia A and inhibitors in Spain.
Jimenez-Yuste V; Núñez R; Romero JA; Montoro B; Espinós B
Haemophilia; 2013 Nov; 19(6):841-6. PubMed ID: 23758100
[TBL] [Abstract][Full Text] [Related]
6. Activated prothrombin complex concentrate (FEIBA®) for the treatment and prevention of bleeding in patients with acquired haemophilia: A sequential study.
Zanon E; Milan M; Gamba G; Ambaglio C; Saggiorato G; Spiezia L; Montani N; Prandoni P
Thromb Res; 2015 Dec; 136(6):1299-302. PubMed ID: 26505666
[TBL] [Abstract][Full Text] [Related]
7. Acquired haemophilia A presenting at a District General Hospital.
Freeman A
BMJ Case Rep; 2015 Feb; 2015():. PubMed ID: 25691577
[TBL] [Abstract][Full Text] [Related]
8. Low thrombin generation during major orthopaedic surgery fails to predict the bleeding risk in inhibitor patients treated with bypassing agents.
Mancuso ME; Chantarangkul V; Clerici M; Fasulo MR; Padovan L; Scalambrino E; Peyvandi F; Tripodi A; Santagostino E
Haemophilia; 2016 Jul; 22(4):e292-300. PubMed ID: 27197961
[TBL] [Abstract][Full Text] [Related]
9. Complete immunotolerance induction after FEIBA prophylaxis in a haemophilia A patient with high-titre inhibitor.
Nanishi E; Ohga S; Doi T; Ishimura M; Ihara K; Takada H; Shima M; Hara T
Haemophilia; 2012 May; 18(3):e75-7. PubMed ID: 22404696
[No Abstract] [Full Text] [Related]
10. Successful bleeding control with recombinant porcine factor VIII in reduced loading doses in two patients with acquired haemophilia A and failure of bypassing agent therapy.
Stemberger M; Möhnle P; Tschöp J; Ney L; Spannagl M; Reincke M
Haemophilia; 2016 Sep; 22(5):e472-4. PubMed ID: 27480782
[No Abstract] [Full Text] [Related]
11. Inhibitors of fibrinolysis in the treatment of haemophilia.
Rizza CR
J Clin Pathol Suppl (R Coll Pathol); 1980; 14():50-4. PubMed ID: 7000847
[No Abstract] [Full Text] [Related]
12. Dental extractions in patients with mild hemophilia A and hemophilia B and von Willebrand disease without clotting factor supplementation.
Lewandowski B; Wojnar J; Brodowski R; Mucha M; Czenczek-Lewandowska E; Brzęcka D
Pol Arch Intern Med; 2018 Aug; 128(7-8):488-490. PubMed ID: 30057379
[No Abstract] [Full Text] [Related]
13. Management of third molar removal with a single dose of recombinant Factor IX (BeneFIX) and local measures in severe haemophilia B.
Hewson ID; Makhmaloaf P
Aust Dent J; 2010 Sep; 55(3):322-4. PubMed ID: 20887522
[TBL] [Abstract][Full Text] [Related]
14. Major orthopaedic surgery for a haemophilia patient with inhibitors using a new bypassing agent.
Takedani H; Hirose J; Minamoto F; Kubota M; Kinkawa J; Noguchi M
Haemophilia; 2016 Sep; 22(5):e459-61. PubMed ID: 27456673
[No Abstract] [Full Text] [Related]
15. Tranexamic acid, fibrinogen concentrate, and prothrombin complex concentrate: data to support prehospital use?
Schöchl H; Schlimp CJ; Maegele M
Shock; 2014 May; 41 Suppl 1():44-6. PubMed ID: 24296431
[TBL] [Abstract][Full Text] [Related]
16. The use of topical crushed tranexamic acid tablets to control bleeding after dental surgery and from skin ulcers in haemophilia.
Coetzee MJ
Haemophilia; 2007 Jul; 13(4):443-4. PubMed ID: 17610565
[No Abstract] [Full Text] [Related]
17. Case report: use of topical tranexamic acid to stop localised bleeding.
Noble S; Chitnis J
Emerg Med J; 2013 Jun; 30(6):509-10. PubMed ID: 22833592
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis in haemophilia patients with inhibitors.
Leissinger CA
Haemophilia; 2006 Dec; 12 Suppl 6():67-72; discussion 72-3. PubMed ID: 17123397
[TBL] [Abstract][Full Text] [Related]
19. Complex dental extractions in a patient with severe haemophilia A and inhibitors treated with activated prothrombin complex concentrate.
Zanon E; Brandolin B; Saggiorato G; Bacci C
Blood Transfus; 2012 Apr; 10(2):225-7. PubMed ID: 22337269
[No Abstract] [Full Text] [Related]
20. Dental extraction in congenital hemorrhagic patients.
Dal Bo Zanon R; Calzavara M; Vicari T; Miotti A; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):799-804. PubMed ID: 2436993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
